- Rifabutin for treating pulmonary tuberculosis
- Routine surgery in addition to chemotherapy for treating spinal tuberculosis
- Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews
- Saline nasal irrigation for acute upper respiratory tract infections
- Screening for lung cancer
- Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
- Second‐line chemotherapy for non‐small cell lung cancer
- Selenium supplementation for asthma
- Self‐management education and regular practitioner review for adults with asthma
- Self‐management education for cystic fibrosis
- Self‐management interventions for people with chronic obstructive pulmonary disease
- Short acting beta2-agonists for bronchiectasis
- Short acting beta2‐agonists for recurrent wheeze in children under two years of age
- Short courses of antibiotics for children and adults with bronchiectasis
- Short‐acting beta2‐agonists for stable chronic obstructive pulmonary disease
- Short‐course antibiotics for acute otitis media
- Short‐course versus long‐course antibiotic therapy for non‐severe community‐acquired pneumonia in children aged 2 months to 59 months
- Short-term ambulatory oxygen for chronic obstructive pulmonary disease
- Sildenafil for pulmonary hypertension in neonates
- Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.